Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
31.16
-0.29 (-0.92%)
At close: May 9, 2025, 4:00 PM
31.26
+0.10 (0.32%)
After-hours: May 9, 2025, 6:19 PM EDT
Vaxcyte Employees
Vaxcyte had 414 employees as of December 31, 2024. The number of employees increased by 160 or 62.99% compared to the previous year.
Employees
414
Change (1Y)
160
Growth (1Y)
62.99%
Revenue / Employee
n/a
Profits / Employee
-$1,230,978
Market Cap
4.02B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 414 | 160 | 62.99% |
Dec 31, 2023 | 254 | 96 | 60.76% |
Dec 31, 2022 | 158 | 69 | 77.53% |
Dec 31, 2021 | 89 | 31 | 53.45% |
Dec 31, 2020 | 58 | 15 | 34.88% |
Dec 31, 2019 | 43 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PCVX News
- 3 days ago - Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 10 days ago - Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors - GlobeNewsWire
- 5 weeks ago - Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity - Seeking Alpha
- 5 weeks ago - Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine - Benzinga
- 5 weeks ago - Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study - GlobeNewsWire
- 5 weeks ago - Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study - GlobeNewsWire
- 2 months ago - Vaxcyte, Inc. (PCVX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire